A comparative experimental study of proconvulsive potential of fluoroquinolones

Indian Journal of Pharmacology

Volumn 31, Issue 1, 1999, Pages 29-32

  Rewari, Shalini ^a   Prabhu, S ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Ciprofloxacin; Convulsions; Ofloxacin; Pefloxacin

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; PEFLOXACIN; PENTETRAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG MEGADOSE; ELECTRIC SHOCK; EPILEPTOGENESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RAT;

EID: 0033020493     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ball P. Adverse reactions and interactions of fluoroquinolones. Clin Invest Med 1989;12:28-34.
2. Wolfson JS. Overview of fluoroquinolone safety. Am J Med 1991;91 (Suppl 6A):153-61.
3. Wijnands WJA, Vree TB, Vanherwaarden. The influence of quinolone derivatives on theophylline clearance. B J Clin Pharmacol 1986;22:677-83.
4. Bercault N, De Masure M, Benhamou CL, Gueveler C. Seizures in the course of prolonged treatment with ofloxacin. Rev Med Interne 1993;14:194.
5. Leroy O, Beuscart C, Sivery B, Sennevilie E, Mouton Y. Efficacy and tolerance of intravenous ofloxacin. Presse Med 1989;18:2050-4.
6. Toman JEP, Guy M. Anticonvulstants In: Laurence DR, Bacharach AL, eds. Evaluation of drug activities Pharmacometrics Vol.I. London and New York, Academic Press, 1964:290.
7. Turner RA. Anticonvulsants. In: Robert A Turner ed. Screening methods in Pharmacology, New York and London, Academic Press, 1965:1 64-5.
8. Ramzan IM, Levy G. Kinetics of drug action in disease states XIX. Effect of experimental liver disease on neurotoxicity of theophylline in rats. J Pharmacol Exp Ther 1987;241:236-8.
9. Arcieri G, Griffith E, Gruenwaldt G, et al. Ciprofloxacin: An update on clinical experience. Am J Med 1987;82 (Suppl 4A):381-6.
10. Simon J, Guyot A, Pefloxacin: Safety in man. J Antimicrob Chemother 1990;26(Suppl B):215-7.
11. Jungst G, Mohr R. Side effects of ofloxacin in clinical trials and in post marketing surveillance. Drugs 1987;34 (Suppl I);144-9.
12. Covelli HD, Knodel AR, Heppner BT. Predisposing factors to apparent theophylline induced seizures. Ann Allergy 1985;54:411-5.
13. Traeger SM, Bonfiglio MF, Wilson JA, Martin BR, Nackes NA. Seizures associated with ofloxacin therapy. Clin Infect Dis 1995;21:1504-6.
14. Thomas RJ, Reagan DR. Association of aTourette like syndrome with ofloxacin. Ann Pharmacother 1996;30:138-41.
15. Walton GD, Hon JK, Mulpur TG. Ofloxacin induced seizures. Ann Pharmacother 1997;3:1475-7.
16. Ball P, Tillotson G. Tolerability of fluoroquinolone antibiotics, past, present and future. Drug safety 1995;13: 343-58.
17. Enginar N, Eroglu L. The effect of ofloxacin and ciprofloxacin on pentylenetetrazol induced convulsions in mice. Pharmacol Biochem Behav 1991;39:587-89.